Sealite Sciences, Inc.

Basic Information

3000 N WOODS PKY, STE 200
Norcross, GA, 30071

Company Profile

n/a

Additional Details

Field Value
DUNS: n/a
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. BIOLUMINESCENT ASSAY FOR QUANTIFYING PCR PRODUCTS

    Amount: $99,372.00

    N/A

    SBIR Phase I 1996 Department of Health and Human Services
  2. Bioluminescent Detection of Mycobacterium Tuberculosis

    Amount: $85,491.00

    Mycobacterial tuberculosis (MTB) has recently reemerged as the leading infectious disease in the wobecause of HIV, drug use, homelessness and poverty. Current diagnostics for MTB are slow and laboriot ...

    SBIR Phase I 1995 Department of Health and Human Services
  3. Cryptosporidosis--A Bioluminescent Cryptosporidium Assay

    Amount: $92,972.00

    There has been a recent concern raised regarding the contamination of water supplies by CryptosporiThis was sparked by the outbreak that occurred in Milwaukee. While contamination by any microbial agC ...

    SBIR Phase I 1995 Department of Health and Human Services
  4. Bioluminescent Immunoassay for Testosterone

    Amount: $74,644.00

    Radioimmunoassays make up a significant percentage of the immunoassays used in clinicallaboratories. Nonradioactive, immunometric or "sandwich" assays using enzymes for signal generation(EIAs) have ge ...

    SBIR Phase I 1994 Department of Health and Human Services
  5. GLYCOSYLATION STATUS ASSAYS FOR DIAGNOSTIC TUMOR MARKERS

    Amount: $49,997.00

    CERTAIN SERUM GLYCOPROTEINS THAT ARE ELEVATED IN THE SERUM OR URINE OF CANCER PATIENTS ARE CONSIDERED TO BE TUMRO MARKERS. ANALYSES OF THE OLIGOSACCHARIDE SIDE-CHAINS ON MANY OF THESE GLYCOPROTEINS, I ...

    SBIR Phase I 1992 Department of Health and Human Services
  6. LUMINESCENCE DETECTION REAGENTS FOR GLYCOLIPIDS

    Amount: $468,906.00

    ALTERATIONS IN SURFACE CARBOHYDRATES IN GLYCOLIPIDS AND GLYCOPROTEINS OF TUMOR CELLS RELATIVE TO NORMAL CELLS IS A COMMON FEATURE OF MALIGNANT DISEASES. IMMUNOSTAINING PROCEDURES DEVELOPED FOR DETECTI ...

    SBIR Phase II 1991 Department of Health and Human Services
  7. LUMINESCENCE DETECTION REAGENTS FOR GLYCOLIPIDS

    Amount: $50,000.00

    N/A

    SBIR Phase I 1989 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government